Janssen Pharmaceuticals, Inc. (Janssen) today announced that results from the Phase 3b PIONEER AF-PCI study with XARELTO® (rivaroxaban) and new INVOKANA® (canagliflozin) research will be...

Minneapolis, Minnesota, November 7, 2016 - Harsh-environment applications encounter increased pressure to reduce size and weight while providing a rugged connectors and interconnect solutions. To...

BlackLine (Nasdaq: BL), a leading provider of financial controls and automation software that enables Continuous Accounting, has long promoted the value of continuous learning. The company...

Rubicon Genomics, Inc. today announced that it will present data on its soon-to-be-launched ThruPLEX® Enrichment Reagent kit at the 2016 Annual Meeting of the Association for Molecular Pathology...

NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), reports that its President Dr. Anil Diwan was recently invited to participate in certain pharmaceutical industry meetings to comment on...